18 February 2023>: Clinical Research
Comparison of 3 Enzyme-Linked Immunoassay Methods to Evaluate Serum Concentrations of Infliximab and Antibodies to Infliximab in 32 Patients with Moderate to Severe Inflammatory Bowel Disease
Tomislav Jukic 1CDEF , David Drobne 2ABCDE , Sasa Pusavec 3BF , Alojz Ihan 3AE , David Stubljar 4ACDE* , Andrej Starc 5DEDOI: 10.12659/MSM.939084
Med Sci Monit 2023; 29:e939084
Table 3 Comparison of samples between University of Leuven (UHL) test and apDia test: number of samples in a respective group.
TL IFX <3 μg/mL – UHL | TL IFX=3–7 μg/mL – UHL | TL IFX >7 μg/mL – UHL | |
---|---|---|---|
TL IFX | 4 | 0 | 0 |
TL IFX=3–7 μg/mL – apDia | 0 | 3 | 0 |
TL IFX >7 μg/mL – apDia | 0 | 5 | 4 |